chlormezanone has been researched along with Migraine Disorders in 1 studies
Chlormezanone: A non-benzodiazepine that is used in the management of anxiety. It has been suggested for use in the treatment of muscle spasm.
chlormezanone : A 1,3-thiazine that is 1,3-thiazinan-4-one S,S-dioxide in which a hydrogen at position 2 is substituted by a 4-chlorophenyl group and the hydrogen attached to the nitrogen is substituted by methyl. A non-benzodiazepine muscle relaxant, it was used in the management of anxiety and in the treatment of muscle spasms until being discontinued worldwide by its manufacturer in 1996, due to rare but serious cutaneous reactions.
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tfelt-Hansen, P | 1 |
| Jensen, K | 1 |
| Vendsborg, P | 1 |
| Lauritzen, M | 1 |
| Olesen, J | 1 |
1 trial available for chlormezanone and Migraine Disorders
| Article | Year |
|---|---|
Chlormezanone in the treatment of migraine attacks: a double blind comparison with diazepam and placebo.
Topics: Acetaminophen; Chlormezanone; Clinical Trials as Topic; Diazepam; Double-Blind Method; Drug Therapy, | 1982 |